Optimal implementation of the 2019 ESC/EAS dyslipidaemia guidelines in patients with and without atherosclerotic cardiovascular disease across Europe: a simulation based on the DA VINCI studyResearch in context

Optimal implementation of the 2019 ESC/EAS dyslipidaemia guidelines in patients with and without atherosclerotic cardiovascular disease across Europe: a simulation based on the DA VINCI studyResearch in context

Summary: Background: The impact of the stepwise implementation of the 2019 European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) treatment algorithm on low-density lipoprotein cholesterol (LDL-C) goal attainment was simulated in patients from the DA VINCI study. Methods: Monte...

Full description

Bibliographic Details
Main Authors: Julia Brandts, Sarah Bray, Guillermo Villa, Alberico L. Catapano, Neil R. Poulter, Antonio J. Vallejo-Vaz, Kausik K. Ray
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:The Lancet Regional Health. Europe
Subjects:
Atherosclerotic cardiovascular disease
LDL-C
Lipid-lowering
ESC/EAS guidelines
Cardiovascular risk
Online Access:http://www.sciencedirect.com/science/article/pii/S2666776223000844

Internet

http://www.sciencedirect.com/science/article/pii/S2666776223000844

Similar Items